Benzinga | Nov 11, 2020 04:07PM EST

PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate

PDL BioPharma (NASDAQ:PDLI) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.06 by 33.33 percent. This is a 55.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $4.12 million which missed the analyst consensus estimate of $5.50 million by 25.18 percent. This is a 90.68 percent decrease over sales of $44.16 million the same period last year.